CD200

CD200

CD200 Overview

Molecule Name
OX-2 membrane glycoprotein
Synonyms
CD200,MOX1,MOX2,MRC,OX-2,My033
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
My033,CD200,CD200 Antigen,Antigen Identified By Monoclonal Antibody MRC OX-2,MOX1,OX-2 Membrane Glycoprotein,OX-2,MRC,CD200 Molecule,MOX2
Background
CD200 is also known as OX-2 membrane glycoprotein (OX-2), is a type-1 membrane glycoprotein, which contains two immunoglobulin domains (1 Ig-like C2-type (immunoglobulin-like) domain and Ig-like V-type (immunoglobulin-like) domain), and thus belongs to the immunoglobulin superfamily. CD200 / OX-2 is widely expressed in multiple cell types. CD200 interacts with a structurally related receptor (CD200R) expressed mainly on myeloid cells and is involved in regulation of macrophage and mast cell function. OX-2 / CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.

CD200 Product List

Species
  • Human(3)
  • Mouse(1)
Tag
  • Fc Tag & Avi Tag(2)
  • Fc Tag(1)
  • His Tag(1)
Host
  • HEK293(4)
Conjugate
  • Biotin-labeled(2)
  • Unconjugated(2)
Grade
  • RUO(4)
Low Endotoxin
  • Yes(2)
  • No(2)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
CD200
Human CD200 / OX-2 Protein, His Tag, low endotoxin
Human
HEK293
SDS-PAGE
ELISA

$300.00

100ug
CD200
Human CD200 / OX-2 Protein, Fc Tag, low endotoxin
Human
HEK293
SDS-PAGE
ELISA

$275.00

100ug
CD200
Avitag
OX2-H82F1
Biotinylated Human CD200 / OX-2 Protein, Fc,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
CD200
Avitag
OX2-M82F3
Biotinylated Mouse CD200 / OX-2 Protein, Fc,Avitag™ (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme Inc
Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
Customer Reviews